Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device

Heart Lung and Circulation

Volumn 23, Issue 3, 2014, Pages 229-233

  Deo, Salil V ^a   Sharma, Vikas ^a   Altarabsheh, Salah E ^a   Hasin, Tal ^a   Dillon, John ^a   Shah, Ishan K ^a   Durham, Lucian A ^a   Stulak, John M ^a   Daly, Richard C ^a   Joyce, Lyle D ^a   Park, Soon J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Congestive heart failure; Hemodialysis; Hepatic function; Left ventricular assist device; Renal function

Indexed keywords

BILIRUBIN; CREATININE; NITROGEN; UREA;

AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UREA NITROGEN BLOOD LEVEL;

CONGESTIVE HEART FAILURE; HEMODIALYSIS; HEPATIC FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; RENAL FUNCTION;

AGED; BILIRUBIN; CREATININE; HEART-ASSIST DEVICES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; MIDDLE AGED; RETROSPECTIVE STUDIES; UREA;

EID: 84896735364     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.07.021     Document Type: Article

References (12)

1. Park S.J., Milano C.A., Tatooles A.J., Rogers J.G., Adamson R.M., Steidley D.E., et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012, 5(2):241-248.
2. Letsou G.V., Myers T.J., Gregoric I.D., Delgado R., Shah N., Robertson K., et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann Thorac Surg 2003, 76:1167-1170.
3. Russell S.D., Rogers J.G., Milano C.A., Dyke D.B., Pagani F.D., Aranda J.M., et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation 2009, 120:2352-2357.
4. Matthews J.C., Pagani F.D., Haft J.W., Koelling T.M., Naftel D.C., Aaronson K.D. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010, 121:214-220.
5. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
6. Kirklin J.K., Naftel D.C., Kormos R.L., Stevenson L.W., Pagani F.D., Miller M.A., et al. Second INTERMACS annual report: more than 1000 primary left ventricular assist device implants. J Heart Lung Transplant 2010, 29:1-10.
7. Kihara S., Litwak K.N., Nichols L., Litwak P., Kameneva M.V., Wu Z., et al. Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist. Ann Thorac Surg 2003, 75:178-183. [discussion 83].
8. Saito S., Westaby S., Piggot D., Dudnikov S., Robson D., Catarino P.A., et al. End-organ function during chronic nonpulsatile circulation. Ann Thorac Surg 2002, 74:1080-1085.
9. Radovancevic B., Vrtovec B., de Kort E., Radovancevic R., Gregoric I.D., Frazier O.H. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant 2007, 26:815-818.
10. Sandner S.E., Zimpfer D., Zrunek P., Dunkler D., Schima H., Rajek A., et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant 2008, 27:469-473.
11. Hasin T., Topilsky Y., Schirger J.A., Li Z., Zhao Y., Boilson B.A., et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol 2012, 59:26-36.
12. Wadia Y., Etheridge W., Smart F., Wood R.P., Frazier O.H. Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support. J Heart Lung Transplant 2005, 24:361-370.